Study shows that VEGF-A can increase expression of dopamine D2 receptors on endothelial cells

Study shows that VEGF-A can increase expression of dopamine D2 receptors on endothelial cells

Researchers have identified a new molecular drug target that could result in new cancer drugs with fewer side effects.

Comments are closed.

Research brings hope for spinal cord injury treatment
20 May 2022
Research sheds light on crimean-congo hemorrhagic fever disease process
20 May 2022